跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JAMP TOBRAMYCIN / DEXAMETHASONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
JAMP TOBRAMYCIN / DEXAMETHASONE
Authorized
STANDARD
JAMP TOBRAMYCIN / DEXAMETHASONE
Jamp Pharma Corporation
🇨🇦 Health Canada
Approval Date
Sep 4, 2026
Approval ID
e480fcdd3fc9eb38
Company
Jamp Pharma Corporation
Type
Standard
Approval Details
Approval Id
e480fcdd3fc9eb38
Drug Approval Canada Name
JAMP TOBRAMYCIN / DEXAMETHASONE
Product Name
JAMP TOBRAMYCIN / DEXAMETHASONE
Status
Approved
Status Date
2026-09-01
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Ophthalmic
Schedule
PRESCRIPTION
Atc Original
S01CA01 DEXAMETHASONE AND ANTIINFECTIVES
Aig Number
0220325001
Company Name
Jamp Pharma Corporation
Company Address
1310 Rue Nobel Boucherville Quebec Canada J4B 5H3
Company Detail Path
/organization/jamp-pharma-corporation
Company Information
Pharmaceutical Company Name
Jamp Pharma Corporation
Country Name
Canada
Province Name
British Columbia
City Name
chilliwack,british columbia,country_ca
Address
8065 Aitken Rd
Active Ingredients
DEXAMETHASONE
0.1 % / W/V
TOBRAMYCIN
0.3 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Sep 4, 2026
Approval ID
e480fcdd3fc9eb38
Type
Standard
Back to Health Canada Approvals